Prevalence and levels of autoantibodies in cerebrospinal fluid of patients with central and peripheral NPSLE at baseline and 6 months^A

AThe baseline evaluation was at the time of hospitalization. The NMDAR antibody was measured in 23 central and 5 peripheral NPSLE patients at baseline and 6 months. BOnly patients who scored positive at baseline for the specific antibody were considered: Central NPSLE/Peripheral NPSLE anti-dsDNA 17/3, anti-ribosomal P 10/2, anticardiolipin IgG 4/0, anti-NMDAR 9/0.